​Kembara Xtra - Medicine - Infectious Mononucleosis ( Epstein Barr Virus Infections)

​Kembara Xtra - Medicine - Infectious Mononucleosis ( Epstein Barr Virus Infections) 
Epstein-Barr virus (EBV) is a type 4 human herpesvirus and a member of the herpesvirus family. two subtypes ST1 is the more common in the Western Hemisphere and Southeast Asia; ST1 and ST2 are equally common in Africa.

Primary infections usually happen in children. By the time they are 2 years old, the majority of people seroconvert with few clinical symptoms of disease. Young adulthood and adolescence mark the second peak.

Due of its link to cancer, the WHO designated EBV as a "tumor virus" (category I carcinogen).

Military recruits, college students, and those living in close-knit communities had the highest rates of symptomatic infection, according to epidemiology incidence. The United States' overall rate is 500 per 100,000.
The incidence rises throughout the summer months; the most common age for symptomatic initial infection is 15 to 24 years; 200 to 800/100,000 are affected.

95% of people worldwide have contracted the disease by maturity. 50% of kids have the infection by the age of 5, with the majority of them not showing any symptoms.

In affluent nations, seroconversion happens later in childhood. In the United States, communities of non-Hispanic black, Asian, and Hispanic descent have greater seroprevalence rates than other demographics. A higher incidence is also present in larger homes, and parental education levels are lower.

Pathophysiology and Etiology 

The virus reproduces in the nasopharyngeal epithelium after inoculation, leading to cell lysis, virion dissemination, and viremia. EBV has a dual preference for epithelial and B cells. Atypical lymphocytes manifest in the peripheral circulation as a result of the reticuloendothelial system being compromised, which also causes a host reaction. One week before symptoms, the viral genome in the oral cavity can be found.
The next step is a polyclonal B-cell proliferative response.
Only a small percentage (0.1%) of the circulating lymphocytes carry the EBV infection during the acute sickness.
● It then enters a chronic (asymptomatic) state where the immune system cannot detect the EBV genome. The EBV particles' ability to encase themselves in membranes formed from host cells is assumed to be what maintains the invisible condition (to host immunity).
The previously dormant EBV-infected B cells proliferate and enter a "lytic" phase, allowing clinical manifestation of the EBV genome, either through B-cell stimulation or decreased EBV-specific immune regulation. Smoking, an increase in BMI, low vitamin D levels from inadequate sun exposure, and host genetic factors may all increase the risk of this happening. The proteins generated could either alter the host's response to cancer or directly cause it.

Transformation and lymphoproliferative diseases can be brought on by immunosuppression (organ transplant/acquired immune deficiency).

Risk factors include age (adolescents and young adults have the highest prevalence of symptomatic infection), sociohygiene level ("crowded conditions"), location, and close, intimate contact, notably "deep kissing" in this age group.
Immunosuppression Potentially some danger of infection from insects (such as through sharing toys)

Prevention 

 Keep your distance from people who have EBV/IM symptoms.
EBV vaccines are being researched (lack of intimate knowledge of immune response mechanism has impaired ability to develop an effective vaccine), meticulous hand washing and hygiene, general precautions with potential blood exposure (EBV can be transmitted via blood contamination as well as hematopoietic cell and solid organ transplant), and 

Accompanying Conditions 
Infectious mononucleosis (IM): In otherwise healthy adolescents and young adults, symptomatic primary EBV infection is frequent.
– Clinical characteristics range in intensity and duration: Symptoms are typically moderate in children under 10 years old, but they can become more severe and last longer in adults (depending on the strength of the T-cell response) (2).
– For a viral infection, the incubation period is exceptionally long at 30 to 50 days.
X-linked lymphoproliferative syndrome (XLP) (rare, hereditary condition that causes heightened susceptibility to EBV infection)
Hairy leukoplakia of the tongue, leiomyosarcoma, and CNS lymphomas in AIDS patients; Lymphoproliferative syndromes caused by EBV infections in transplant recipients; Lymphomas (B-cell lymphoblastic, T cell); Lymphocytic interstitial pneumonitis; 
Nasopharyngeal carcinoma (found worldwide but with the highest prevalence in Africa and Asia) Burkitt lymphoma (most prevalent childhood tumor in Africa and Papua New Guinea where malaria is also endemic and may be a cofactor)
Hodgkin lymphoma, the most prevalent cancer linked to the EBV in the United States and the European Union, and parotid carcinoma
Suspected to be related to multiple sclerosis (incidence 2 to 3 times higher in EBV-positive people).
Due to a loss of host control over viral replication, the Epstein-Barr virus can become chronically active (CAEBV).

Presenting the History Syndrome of weariness, malaise, and sore throat may appear suddenly or develop slowly.

In extreme cases, temperature increases of 104 to 105°F (40.0 to 40.6°C) may continue for 2 weeks; in adults, temperature may rise to 103°F (39.4°C) and gradually descend over a varied period of 7 to 10 days. Children often have low-grade fevers or are afebrile.
Rash and red eyes
Myocarditis and pericarditis-related chest pain


clinical assessment 
More than 50% of patients have fever, lymphadenopathy, and pharyngitis; yet, only 10% also have palatal petechiae and hepatosplenomegaly.
Gelatinous, grayish-white exudative tonsillitis persists for 7 to 10 days in 50% of cases, as do diffuse hyperemia and hyperplasia of oropharyngeal lymphoid tissue.
Petechiae are seen on 60% of the hard and soft palate borders.
Axillary, epitrochlear, popliteal, inguinal, mediastinal, and mesenteric lymphadenopathy (95% of patients) and bilateral upper eyelid edema (Hoagland sign)

Lymph node hypertrophy goes away within a few days or weeks.
Tender lymphadenopathy (the most typical enlargement is of the cervical nodes.)
A 50% splenomegaly rate
Skin issues affect 3–16% of people.
Rash commonly appears on the torso and upper arms, but it can also occur on the face and forearms. Petechial and purpuric exanthems have also been observed.

Differential diagnoses include acute HIV infection, blood dyscrasias, rubella, measles, viral hepatitis, cytomegalovirus, toxoplasmosis, and tonsillitis caused by streptococcal bacteria.

Initial test results from the laboratory and imaging
With differential, CBC
Increased numbers of lymphocytes, particularly atypical lymphocytes, in peripheral blood (up to 70% of leukocytes); in the first week following initiation, WBC count is normal or modestly lowered. Automated processing can cause pseudoneutropenia because of the fragility of neutrophils caused by EBV.
Atypical lymphocytosis appears by week two.
– Early in the illness, the EBV transforms B cells into atypical lymphocytes; afterwards, atypical cells become activated CD8 T lymphocytes.
80% to 90% of persons have heterophile antibodies. The sensitivity of the Monospot (latex agglutination) test varies from 70% to 90%, however it is very specific.
Heterophile antibody is an IgM response that manifests during the first two weeks of illness and vanishes in four to six weeks (children under the age of four have a higher false-negative rate).
- Agglutinin titer is typically higher in IM than other illnesses; a heterophile unabsorbed titer of between 1:128 and 1:40 is significant.
Regular development of specific antibodies to EBV-associated antigens in IM
- Early in the illness, viral capsid-specific IgM and IgG are detectable.
- Viral capsid-IgM vanishes after a few weeks, however viral capsid-IgG remains throughout one's lifetime.
Transaminitis and hyperbilirubinemia are common liver testing results; jaundice is uncommon.
Atypical lymphocytes can be found in different clinical disorders such as rubella, infectious hepatitis, allergic rhinitis, asthma, and atypical pneumonia; they are not just present in EBV infections.
It is not required to regularly perform abdominal ultrasonography to check for splenic enlargement.
If you want to resume rigorous activities or contact sports after day 21 of illness, consider getting an ultrasound to rule out splenomegaly.

Tests in the Future & Special Considerations
Hepatomegaly affects 15-20% of patients, while 80% of patients have abnormal liver enzymes that last for several weeks. In transplant recipients, quantitative polymerase chain reaction (PCR) is utilized to track EBV burdens.
Diagnostic techniques/other x-rays of the chest

In IM with significant lymphoid hyperplasia, hilar adenopathy may be seen.
Mononuclear infiltrations of the lymph nodes, tonsils, spleen, lungs, liver, heart, kidneys, adrenal glands, skin, and central nervous system may be present; however, these findings are nonspecific and have little bearing on prognosis.

Treatment is mostly supportive in nature.
NSAIDs or acetaminophen Limit activities for 4 weeks during the acute period to prevent complications (such as splenic rupture).
When transplant recipients contract EBV, immunosuppressive medication may need to be changed, and monoclonal anti-CD20 (rituximab) may need to be given.


Medication In cases of primary infections, antibiotics (often penicillin) should only be taken if a throat culture shows the presence of group A hemlytic streptococci.
Rashes after beta-lactam antibiotic therapy are substantially less common than formerly believed.
- Corticosteroids - Warm saline gargles for oropharyngeal discomfort
Consider in cases of severe pharyngotonsillitis with oropharyngeal edema and airway encroachment. May provide some clinical relief, but no improvement in illness resolution.
For one to three days, dexamethasone 0.3 mg/kg/day may be utilized.
Additionally, for patients who experienced significant side effects or complications (such as neurologic sequelae, myocarditis, pericarditis, hemolytic anemia, or thrombocytopenic purpura), antiviral drugs like acyclovir have been shown in small studies to hasten recovery and lessen subjective symptoms in patients with acute EBV infection.

Referral 

In the majority of cases, a referral to a specialist is not necessary for outpatient management. For problems such oropharyngeal edema with compromised airways, consider referral.

Surgical Techniques 
With significant thrombocytopenia that is resistant to corticosteroids, a splenectomy may be required.
Hematopoietic stem cell transplantation remains the only successful treatment for XLP at this time. Monoclonal antibodies are occasionally used to stop progression prior to HST or to treat relapse after transplant.
Splenic dislocation

Proceed With Caution 
Spleen rupture necessitates blood transfusions, shock treatment, and splenectomy and may be fatal if untreated. 0.1% is the estimated frequency.
patient observation
Avoid contact sports, strenuous exercise, and heavy lifting until the liver and spleen have grown back to their normal sizes (ultrasound can confirm this). The general agreement nowadays is that patients can resume contact sports activities after three weeks with a normal exam, no fever, and no constitutional problems.
Stop drinking alcohol and avoid other hepatotoxic substances until LFTs are back to normal.
The likelihood of problems is greatest in the first three weeks from the start of the illness, while symptoms including malaise, fatigue, intermittent sore throats, and lymphadenopathy can last for months.

​Diet
No limitations on diet. Water intake is critical.

Prognosis 
Fatigue may last for months. Most people recover in 4 weeks.

Complications 
Hematologic (rare) - Transverse myelitis - Cerebellar ataxia - Acute psychosis - Neurologic (rare) - Aseptic meningitis, meningoencephalitis - Bell palsy, Guillain-Barré syndrome -
Early-stage thrombocytopenia and early-stage hemolytic anemia with neutropenia
Agammaglobulinemia, Pneumonitis, Airway Obstruction, and Splenic Rupture - Rare but most frequently happens in the first 21 days of sickness; Hemophagocytic Syndrome (Splenomegaly, Fever, and Cytopenia);

---